Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Lymphoma, Large B-Cell, Diffuse 216Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 172Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 123Hodgkin Disease 112Leukemia 104Recurrence 100Lymphoma, Mantle-Cell 89Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 60Lymphoma, Extranodal NK-T-Cell 56Multiple Myeloma 53Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Neoplasms 39Leukemia, B-Cell 39Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Hematologic Neoplasms 25Mycosis Fungoides 24Lymphoma, Large-Cell, Anaplastic 24Neoplasms, Plasma Cell 23Waldenstrom Macroglobulinemia 22Immunoblastic Lymphadenopathy 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplastic Processes × Lymphoid × Clear all
NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

AO GENERIUM

Phase 1/2 Unknown
36 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡